Here is what you need to look for: Arcturus Therapeutics Holdings Inc. (ARCT) – Invest Chronicle

Here is what you need to look for: Arcturus Therapeutics Holdings Inc. (ARCT)

For the readers interested in the stock health of Arcturus Therapeutics Holdings Inc. (ARCT). It is currently valued at $13.04. When the transactions were called off in the previous session, Stock hit the highs of $16.87, after setting-off with the price of $16.34. Company’s stock value dipped to $12.87 during the trading on the day. When the trading was stopped its value was $16.58.Recently in News on May 9, 2022, Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress. ARCT-154 booster data show 54- and 46-fold increases in neutralizing antibody response against Omicron BA.1 and BA.2. You can read further details here

Arcturus Therapeutics Holdings Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $40.00 on 01/04/22, with the lowest value was $12.87 for the same time period, recorded on 05/11/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

Arcturus Therapeutics Holdings Inc. (ARCT) full year performance was -50.43%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arcturus Therapeutics Holdings Inc. shares are logging -79.94% during the 52-week period from high price, and -17.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $15.71 and $65.00.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1249493 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Arcturus Therapeutics Holdings Inc. (ARCT) recorded performance in the market was -64.77%, having the revenues showcasing -52.25% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 371.77M, as it employees total of 177 workers.

Market experts do have their say about Arcturus Therapeutics Holdings Inc. (ARCT)

During the last month, 6 analysts gave the Arcturus Therapeutics Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 2 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 26.52, with a change in the price was noted -29.96. In a similar fashion, Arcturus Therapeutics Holdings Inc. posted a movement of -69.67% for the period of last 100 days, recording 608,433 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARCT is recording 0.28 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.18.

Technical breakdown of Arcturus Therapeutics Holdings Inc. (ARCT)

Raw Stochastic average of Arcturus Therapeutics Holdings Inc. in the period of last 50 days is set at 0.92%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.00%. In the last 20 days, the company’s Stochastic %K was 3.01% and its Stochastic %D was recorded 5.41%.

Bearing in mind the latest performance of Arcturus Therapeutics Holdings Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -64.77%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -64.01%, alongside a downfall of -50.43% for the period of the last 12 months. The shares increased approximately by -42.28% in the 7-day charts and went up by -49.69% in the period of the last 30 days. Common stock shares were lifted by -52.25% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts